SEC Form 4 · accession 0001209191-17-038610
CERNER CORP /MO/ · CERN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julie M Wilson
Officer — EVP & Chief People Officer
Period of report
Jun 7, 2017
Accepted (ET)
Jun 8, 2017 · 5:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000804753
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 7, 2017 | X | 20,000 | $38.43 | A | 47,526 | D | |
| Common StockF1 | Jun 7, 2017 | X | 40,000 | $44.615 | A | 87,526 | D | |
| Common StockF2,F3,F1 | Jun 7, 2017 | S | 60,000 | $68.15 | D | 27,526 | D | |
| Common Stock | holding | — | — | — | 1,087 | I | by 401(k) Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $38.43 | Jun 7, 2017 | X | 20,000 | D | Mar 9, 2014 | Mar 9, 2022 | Common Stock | 20,000 | 0 | D |
| Non-Qualified Stock Option (right to buy) | $44.615 | Jun 7, 2017 | X | 40,000 | D | Mar 1, 2015 | Mar 1, 2023 | Common Stock | 40,000 | 10,000 | D |
| Non-Qualified Stock Option (right to buy) | $60.37 | holding | — | — | — | Mar 7, 2016 | Mar 7, 2024 | Common Stock | 45,500 | 45,500 | D |
| Non-Qualified Stock Option (right to buy) | $70.91 | holding | — | — | — | Mar 12, 2017 | Mar 12, 2025 | Common Stock | 45,500 | 45,500 | D |
| Non-Qualified Stock Option (right to buy) | $54.01 | holding | — | — | — | Mar 11, 2018 | Mar 11, 2026 | Common Stock | 80,000 | 80,000 | D |
| Non-Qualified Stock Option (right to buy) | $55.74 | holding | — | — | — | Mar 3, 2019 | Mar 3, 2027 | Common Stock | 80,000 | 80,000 | D |
| Restricted Stock Units | $0.00 | holding | — | — | — | Mar 5, 2018 | Mar 5, 2018 | Common Stock | 1,100 | 1,100 | D |
Explanation of responses
- F1Includes 9,000 shares of restricted common stock.
- F2Price reflects a weighted-average price for the transaction. Sale of shares took place at actual prices ranging from $68.03 to $68.28.
- F3Full information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, Cerner Corporation, or a Cerner shareholder.